The Effect of Chan-Chuang Qigong on Fatigue, Exercise Capacity and Quality of Lifpatients With Heart Failure
1 other identifier
interventional
72
1 country
1
Brief Summary
This study aimed to investigate the impact of Chan-Chuang Qigong on fatigue, exercise capacity, quality of life, and heart function in heart failure patients. The study recruited 72 heart failure patients from a medical center in northern Taiwan for an experimental study. The participants were randomly divided into two groups: patients in experimental group was given twice daily, every 15 minutes Chan-Chuang qigong, control group received the regular care for heart failure patients. Data was collected using the Piper Fatigue Scale, a six-minute walking test, and the Minnesota Living with Heart Failure Questionnaire before the intervention as the baseline, and at the 4th, 8th, and 12th weeks during the intervention. It is hoped that through this study, we can understand the effect of Chan-Chuang qigong on improving fatigue, exercise capacity and quality of life in patients with heart failure, and provide an additional choice and reference for the treatment and care of patients with heart failure in the future, and recommend future treatment of heart failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 25, 2023
CompletedFirst Submitted
Initial submission to the registry
July 10, 2024
CompletedFirst Posted
Study publicly available on registry
July 25, 2024
CompletedJuly 25, 2024
July 1, 2024
1.2 years
July 10, 2024
July 24, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Use the Chinese version of Piper fatigue scale to assess fatigue levels.
Use the Chinese version of Piper fatigue scale.There are 16 questions in total. Based on a four-point Likert scale, the minimum score is 16 points and the maximum total score is 64 points. The higher the score, the more serious the fatigue.
before the intervention as the baseline, and at the 4th, 8th, and 12th weeks during the intervention
Use the Six Minute Walking Distance (6MWD) to assess the patient's exercise capacity.
Use the Six Minute Walking Distance (6MWD) to assess the patient's exercise tolerance by measuring the distance the patient walks in a straight line on a surface above 30 meters for 6 minutes.
before the intervention as the baseline, and at the 4th, 8th, and 12th weeks during the intervention
Use the Chinese version of the Minnesota Heart Failure Quality of Life to assess quality of life.
Use the Chinese version of the Minnesota Heart Failure Quality of Life Questionnaire.There are 21 questions in total, scored from 0 to 5, with a total score of 105. The higher the score, the more serious the impact of the disease on life.
before the intervention as the baseline, and at the 4th, 8th, and 12th weeks during the intervention
Secondary Outcomes (2)
heart function-Left ventricular ejection volume
before the intervention as the baseline, and the twelfth week of intervention respectively
heart function-Serum NT-pro BNP values
before the intervention as the baseline, and the twelfth week of intervention respectively
Study Arms (2)
qigong group
EXPERIMENTALPatients in qigong group was given twice daily, every 15 minutes Chan-Chuang qigong
control group
NO INTERVENTIONcontrol group received the regular care for heart failure patients
Interventions
Eligibility Criteria
You may qualify if:
- at least 20 years of age.
- Cardiology specialist diagnoses heart failure based on clinical examination
- Heart failure classified as New York Heart Association class II (NYHA II)
- Left ventricular ejection volume \<50% (HFmrEF and HFrEF)
- According to the doctor's assessment, it is not appropriate to exercise
- Clear consciousness and ability to communicate
- Agree to participate in this study after explanation and sign the consent form
You may not qualify if:
- Renal failure treated with hemodialysis
- Severe arrhythmias, such as third-degree atrioventricular block, frequent ventricular pulses and heartbeats greater than 130 beats/min at rest
- About to undergo coronary interventional surgery or cardiac surgery within 3 months
- Coronary interventional surgery or cardiac surgery in the past 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chia-Lin Hsiehlead
Study Sites (1)
Hsieh Chia Lin
Taipei, 112, Taiwan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant hand nurse
Study Record Dates
First Submitted
July 10, 2024
First Posted
July 25, 2024
Study Start
September 16, 2022
Primary Completion
November 25, 2023
Study Completion
November 25, 2023
Last Updated
July 25, 2024
Record last verified: 2024-07